Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort

Sonja Levy*, Maureen J. B. Aarts, Ferry A. L. M. Eskens, Kristien B. M. Keymeulen, Lukas B. Been, Dirk Grunhagen, Alexander van Akkooi, Mathilde Jalving, Margot E. T. Tesselaar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number001076
Number of pages7
JournalJournal for ImmunoTherapy of Cancer
Volume8
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • immunotherapy
  • skin neoplasms
  • programmed cell death 1 receptor
  • PROGNOSTIC-FACTORS
  • POLYOMAVIRUS
  • CHEMOTHERAPY
  • EPIDEMIOLOGY
  • EXPERIENCE

Cite this